| Astellas Pharma AG - Xtandi 40 mg, Filmtabletten | | 67236 | | 01 | | Xtandi 40 mg | | Filmtabletten | | L02BB04 | | Enzalutamide | | 18.09.2019 | | |
| | Composition | | enzalutamidum 40 mg, hypromellosi acetas succinas, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 3 mg, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Enzalutamidum | 40 mg |
| | BAG: Active Agent | Dose |
|---|
| Enzalutamidum | 40 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosi Acetas Succinas | | | | Hypromellosum | | Überzug | | Macrogol | 8000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 112 | 2869.93 | 3137.65 | B | SL | No |
|
|
